SARS–CoV-2 Immuno-Pathogenesis and Potential for Diverse Vaccines and Therapies: Opportunities and Challenges

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel coronavirus that emerged from Wuhan, China in late 2019 causing coronavirus disease-19 (COVID-19). SARS-CoV-2 infection begins by attaching to angiotensin-converting enzyme 2 receptor (ACE2) via the spike glycoprotein, followed...

Description complète

Détails bibliographiques

Auteurs principaux:	Andrew R. McGill, Roukiah Khalil, Rinku Dutta, Ryan Green, Mark Howell, Subhra Mohapatra, Shyam S. Mohapatra
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2021-02-01
Collection:	Infectious Disease Reports
Sujets:	SARS-COV-2 COVID-19 immunopathogenesis therapeutics vaccines
Accès en ligne:	https://www.mdpi.com/2036-7449/13/1/13
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!